domingo, 27 de agosto de 2023

Bosentan for high-risk outpatients with COVID-19 infection: a randomized, double blind, placebo-controlled trial

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00294-8/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-_o-0wihROd7WBiy7PxYNhHE3lmPARlcHygfMbqEJxGe-Ra4HWZ2Y3Mocx4L2IHDa1SCtTUe9Derxue0bfBhY_aaSaYCw&utm_content=271743104&utm_source=hs_email

No hay comentarios:

Publicar un comentario